HCSG 10-Q: Q3 EPS $0.36; Genesis Recovery Cuts Bad Debt by $6.1M
HCSG sits 49% above its 52-week low of $16.78.
Summary
HCSG's Q3 10-Q confirms the $479.6 million revenue and $0.36 EPS already reported October 21, and details a $6.1 million allowance release tied to the approved Genesis bankruptcy plan that turned bad debt into a benefit.
Key Events · Earnings and Guidance · HCSG
-
Q3 Results Confirmed in 10-Q
Revenue of $479.6 million, up 3.3%, and diluted EPS of $0.36, matching the October 21 8-K; nine-month net income was $73.6 million versus $27.8 million a year ago.
-
Genesis Plan Drives $6.1M Allowance Release
The October 14 bankruptcy court approval of the Genesis plan, backed by a $150 million settlement and an asset sale leaving about $250 million for unsecured creditors, led HCSG to reduce its doubtful-account allowance by $6.1 million, producing a $3.6 million bad debt benefit this quarter.
-
Cash Flow Lags Prior Year
Nine-month operating cash flow was $95.8 million versus $127.6 million a year ago, as accounts and notes receivable absorbed $41.5 million of cash.
-
Buybacks and NEXDINE Draw Down Cash
The company repurchased $56.6 million of stock in nine months and funded the $93.5 million NEXDINE acquisition with cash on hand after quarter-end, against $134.6 million of cash at September 30.
Analysis · HCSG · Industrial Applications And Services
The headline numbers were already out on October 21, but the 10-Q adds the mechanics behind them. The Genesis bankruptcy plan approved October 14 — a $150 million litigation settlement plus an asset sale leaving roughly $250 million for unsecured creditors — let HCSG cut its allowance on Genesis receivables by $6.1 million, which is why bad debt expense was a $3.6 million benefit this quarter instead of a charge. Nine-month net income of $73.6 million against $27.8 million a year ago is mostly that bad-debt swing, not an operating step-change: revenue grew 3.1% to $1.413 billion while operating cash flow fell to $95.8 million from $127.6 million on a $41.5 million receivables build. The company also spent $56.6 million on buybacks in nine months, and the $93.5 million NEXDINE deal closed October 6 using cash on hand, so the balance sheet has since shrunk from the $134.6 million cash reported here.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 29.2% of the 1549 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HCSG was trading at $25.07 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $16.78 to $25.75. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.